William Harnisch’s Pfizer PFE Stock Holding History

William Harnisch’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,540	Closed	-$441K	–	50
2018 Q3	$441K	Hold	10,540	–	–	0.11%	26
2018 Q2	$363K	Hold	10,540	–	–	0.07%	25
2018 Q1	$355K	Hold	10,540	–	–	0.07%	26
2017 Q4	$362K	Hold	10,540	–	–	0.05%	40
2017 Q3	$357K	Hold	10,540	–	–	0.06%	33
2017 Q2	$336K	Hold	10,540	–	–	0.05%	43
2017 Q1	$342K	Buy	+10,540	New	+$332K	0.04%	41

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Harnisch's PFE Position: Q4 2018 in Review

William Harnisch sold out of Pfizer (PFE) in Q4 2018, closing a stake of 10,540 shares — an estimated $441K sold.

William Harnisch first reported a position in PFE in Q1 2017 and held it in 7 quarters. The position peaked at $441K in Q3 2018. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

William Harnisch reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
William Harnisch sold 10,540 Pfizer shares in Q4 2018, an estimated $441K.
William Harnisch first reported a position in Pfizer in Q1 2017 and held it in 7 quarters.
William Harnisch's Pfizer position peaked at $441K in Q3 2018.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Peconic Partners's 13F filing for Q4 2018, filed 14 Feb 2019.